FDP
BBIO icon

Financiere des Professionnels’s BridgeBio Pharma BBIO Stock Holding History

Financiere des Professionnels’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Sell
7,680
-220
-3% -$15.4K 0.03% 234
2026
Q1 		$587K Buy
+7,900
New +$573K 0.03% 230

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Financiere des Professionnels's BBIO Position: Q2 2026 in Review

Financiere des Professionnels reduced its BridgeBio Pharma (BBIO) stake by 2.8% in Q2 2026, selling an estimated $15.4K and leaving 7,680 shares worth $572K. The position accounts for 0.03% of the portfolio, ranked #234.

Financiere des Professionnels first reported a position in BBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $587K in Q1 2026. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Financiere des Professionnels held 7,680 shares of BridgeBio Pharma worth $572K as of Q2 2026.
  • Financiere des Professionnels sold 220 BridgeBio Pharma shares in Q2 2026, an estimated $15.4K.
  • BridgeBio Pharma made up 0.03% of Financiere des Professionnels's portfolio in Q2 2026, its #234 holding.
  • Financiere des Professionnels first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 2 quarters since.
  • Financiere des Professionnels's BridgeBio Pharma position peaked at $587K in Q1 2026.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.